Evaluation of the protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing BmAMA1 as vaccines against Babesia microti infection in hamster
In the present study, we have investigated the protective effect of a heterologous prime-boost strategy with priming plasmid DNA followed by recombinant adenovirus, both expressing BmAMA1, against Babesia microti infection. Four groups consisting of 3 hamsters per group were immunized with pBmAMA1/Ad5BmAMA1, pNull/Ad5BmAMA1, pBmAMA1/Ad5Null and pNull/Ad5Null, followed by challenge infection with B. microti. Our results showed that hamsters immunized with plasmid and adenovirus expressing BmAMA1 developed a robust IgG and IgG2a antibody response against BmAMA1, suggesting the DNA vaccine or viral vector vaccine tend to induce a Th1-biased response. Compared to the control hamsters, the hamsters vaccinated either with the prime-boost strategy or one of the two “vaccines” exhibited no significant protection against B. microti challenge. Although a slight difference in terms of parasitemia and hematocrit values at days 14–16 post challenge infection was observed, no other statistical difference was detected. Our results indicate that the prime-boost vaccination strategy of injection of plasmid and adenovirus expressing BmAMA1 is not efficient in protecting against B. microti infection.
KeywordsBabesia microti DNA vaccine Adenovirus Heterologous prime-boost BmAMA1
Unable to display preview. Download preview PDF.
- Caetano, B.C., Bruña-romero, O., Fux, B., Mendes, E.A., Penido M.L.O., Gazzinelli, R.T., 2006. Vaccination with Replication-Deficient Recombinant Adenoviruses Encoding the Main Surface Antigens of Toxoplasma gondii Induces Immune Response and Protection Against Infection in Mice. Human Gene Therapy 17, 415–426CrossRefGoogle Scholar
- Dutta, S., Sullivan, J.S., Grady, K.K., Haynes, J.D., Komisar, J., Adrian H., et al., 2009. High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model PLoS One 4, e8138. DOI: 10.1371/journal.pone.0008138Google Scholar
- Hildebrandt, A., Hunfeld, K.P., Baier, M., Krumbholz, A., Sachse, S., Lorenzen, T., et al., 2007. First confirmed autochthonous case of human Babesia microti infection in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 26, 595–601. DOI:10.1007/s10096-007-0333-1CrossRefGoogle Scholar
- Indresh, K.S., Margaret, A.L., 2013. Gene Vaccines. Ann. Annals of Internal Medicine, 138, 550–559Google Scholar
- Ramshaw, I.A., Ramsay, A.J., 2000. The prime-boost strategy: exciting prospects for improved vaccination. Immunology Today, 21Google Scholar
- Stowers, A.W., Kennedy, M.C., Keegan, B.P., Saul, A., Long, C.A., Miller, L.H., Mmun I.N.I., 2002. Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria. Infection and Immunity 86, 6961–6967. DOI: 10.1128/IAI.70.12.6961CrossRefGoogle Scholar
- Takeda, A., Igarashi, H., Nakamura, H., Kano, M., Iida, A., Hirata, T., et al., 2003. Protective Efficacy of an AIDS Vaccine, a Single DNA Priming Followed by a Single Booster with a Recombinant Replication-Defective Sendai Virus Vector, in a Macaque AIDS Model. Journal of Virology 92, 9710–9715. DOI: 10.1128/JVI.77.17.9710Google Scholar
- Wang, G., Efstratiou, A., Franck, P., Moumouni, A., Liu, M., 2017. Experimental Parasitology Expression of truncated Babesia microti apical membrane protein 1 and rhoptry neck protein 2 and evaluation of their protective efficacy. Experimental Parasitology. 172, 5–11. DOI: 10.1016/j.exppara.2016.11.001CrossRefGoogle Scholar
- Yu, L., Yamagishi, J., Zhang, S., Jin, C., Oluga, G., 2012. Parasitology International Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitology International, 61, 481–486. DOI: 10.1016/j.parint.2012.04.001CrossRefGoogle Scholar